Pharmacy Report Archives - Page 7 of 148 - Becker's Hospital Review

AbbVie sues HHS over 340B definition | UMiami Health taps CPO | 10 systems hiring pharmacy leaders | Safety concerns stall Geisinger pharmacy center | Pharma industry's top lobbyist to exit

Plus: High-dose Wegovy launches at $399 for self-paying patients April 9, 2026 1. AbbVie sues HHS over 340B patient definition Full story 2. U of Miami Health System names Baptist Health pharmacy leader as CPO Full story 3. Procurement inconsistency…

Top pharmacy schools: US News | FDA seeks sweeping policy shifts | Leaders debate GLP-1 promise | Judge allows mifepristone by mail | Novel hemophilia gene therapy debuts

Best pharmacy schools, FDA budget overhaul and GLP-1 oncology debate top today’s news April 8, 2026 1. 2026 best pharmacy schools: US News Full story 2. FDA seeks sweeping policy changes in budget proposal Full story 3. Find case studies…

Court vacates 340B hospital purchasing policy | 2 drugmakers join TrumpRx | FDA issues new compounded GLP-1 rules | DEA suspends Tenn. pharmacy | Ore. passes mobile pharmacy bill

340B policy vacated, TrumpRx expands and GLP-1 guidance top today’s news April 7, 2026 1. Court vacates 340B policy on hospital drug purchasing: 6 things to know Full story 2. 2 more drugmakers join TrumpRx Full story 3. What C-suite…

Why hospital pharmacy AI pilots stall | The case for protecting 340B | CDC flags new sedative in fentanyl supply | Trump imposes drug import tariff | 3.1M eye drops recalled

Pharmacy AI hurdles, 340B debate and 100% drug tariff top today’s news April 6, 2026 1. AI in pharmacy: Why pilots stall at hospitals Full story 2. System CEO: 340B is not a problem to be solved, but a promise…

12 pharmacy leaders on what's ahead | FDA OKs Lilly's GLP-1 weight loss pill | Court upholds block on W.Va. 340B law | 10 systems hiring pharmacy leaders | MD, PharmD rank highest for ROI

Lilly GLP-1 pill approval, 340B ruling and pharmacy outlook top today’s news April 2, 2026 1. Optimists, pessimists and realists — 12 pharmacy leaders on the future Full story 2. FDA approves Eli Lilly's GLP-1 pill for weight loss Full…

Pharmacy leaders outline top bets | Amgen drug under FDA scrutiny after deaths | Novartis challenges Wash. 340B law | 13 potential GLP-1 benefits | Flu shot label adds seizure warning

Amgen safety review, 340B legal battle and GLP-1 insights top today’s news April 1, 2026 1. The big bets 20 pharmacy leaders are making right now Full story 2. Amgen drug under FDA review in wake of 8 deaths Full…

Retail pharmacy growth pressures hospitals | Novo launches Wegovy subscription | CVS eyes net store growth | GLP-1s show addiction treatment potential | FDA OKs 1st pediatric immune gene therapy

Plus: Republicans eye healthcare cuts to fund Iran war March 31, 2026 1. Retail pharmacy growth raises stakes for hospitals Full story 2. Novo offers Wegovy subscription program Full story 3. Up to 9 systems for 1 therapy start. Fix…

6 notes on the pharmacy tech workforce | Drugs most at risk amid Iran conflict | Top PBMs by 2025 share | 4 ways GLP-1s are changing care | FDA OKs 1st weekly basal insulin

Iran drug supply risks, pharmacy tech workforce updates and GLP-1 notes top today’s news March 30, 2026 1. 6 things to know about the pharmacy technician workforce Full story 2. The medications most at risk amid Iran war-driven supply threats…

Lawmakers push $35 insulin cap | Hunter syndrome gets 1st drug in decades | Fla. restores HIV drug access | House panel warns on China's drug supply role | CMS' GLP-1 pilot: 6 key notes

$35 insulin bill, new Hunter syndrome therapy and China drug supply warning top today’s news March 26, 2026 1. Bipartisan bill would cap insulin at $35 per month Full story 2. FDA OKs 1st Hunter syndrome therapy in decades Full…

Covenant Health taps CPO | After GLP-1s, what's next? | HHS invests $8.3M to boost hospital drug supply | FTC nears settlement with CVS Caremark | ADHD drug shortage tied to supply failures

GLP-1 rebound questions, FDA cancer drug warning and CVS settlement lead today’s news March 25, 2026 1. Covenant Health names chief pharmacy officer Full story 2. What happens after patients stop GLP-1s? Full story 3. For Dartmouth Health, alignment between…